Table of Contents

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Hepatitis B RNA Detection Technology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 RT PCR Technology
  • 1.2.3 RNA Isothermal Amplification Technology
• 1.3 Market by Application
  • 1.3.1 Global Hepatitis B RNA Detection Technology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Hepatitis B RNA Detection Technology Market Perspective (2017-2028)
• 2.2 Hepatitis B RNA Detection Technology Growth Trends by Region
  • 2.2.1 Hepatitis B RNA Detection Technology Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Hepatitis B RNA Detection Technology Historic Market Size by Region (2017-2022)
  • 2.2.3 Hepatitis B RNA Detection Technology Forecasted Market Size by Region (2023-2028)
• 2.3 Hepatitis B RNA Detection Technology Market Dynamics
  • 2.3.1 Hepatitis B RNA Detection Technology Industry Trends
  • 2.3.2 Hepatitis B RNA Detection Technology Market Drivers
  • 2.3.3 Hepatitis B RNA Detection Technology Market Challenges
  • 2.3.4 Hepatitis B RNA Detection Technology Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Hepatitis B RNA Detection Technology Players by Revenue
  • 3.1.1 Global Top Hepatitis B RNA Detection Technology Players by Revenue (2017-2022)
  • 3.1.2 Global Hepatitis B RNA Detection Technology Revenue Market Share by Players (2017-2022)
• 3.2 Global Hepatitis B RNA Detection Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Hepatitis B RNA Detection Technology Revenue
• 3.4 Global Hepatitis B RNA Detection Technology Market Concentration Ratio
  • 3.4.1 Global Hepatitis B RNA Detection Technology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B RNA Detection Technology Revenue in 2021
• 3.5 Hepatitis B RNA Detection Technology Key Players Head office and Area Served
• 3.6 Key Players Hepatitis B RNA Detection Technology Product Solution and Service
• 3.7 Date of Enter into Hepatitis B RNA Detection Technology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B RNA Detection Technology Breakdown Data by Type

• 4.1 Global Hepatitis B RNA Detection Technology Historic Market Size by Type (2017-2022)
• 4.2 Global Hepatitis B RNA Detection Technology Forecasted Market Size by Type (2023-2028)

5 Hepatitis B RNA Detection Technology Breakdown Data by Application

• 5.1 Global Hepatitis B RNA Detection Technology Historic Market Size by Application (2017-2022)
• 5.2 Global Hepatitis B RNA Detection Technology Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Hepatitis B RNA Detection Technology Market Size (2017-2028)
• 6.2 North America Hepatitis B RNA Detection Technology Market Size by Type
  • 6.2.1 North America Hepatitis B RNA Detection Technology Market Size by Type (2017-2022)
  • 6.2.2 North America Hepatitis B RNA Detection Technology Market Size by Type (2023-2028)
  • 6.2.3 North America Hepatitis B RNA Detection Technology Market Share by Type (2017-2028)
• 6.3 North America Hepatitis B RNA Detection Technology Market Size by Application
  • 6.3.1 North America Hepatitis B RNA Detection Technology Market Size by Application (2017-2022)
  • 6.3.2 North America Hepatitis B RNA Detection Technology Market Size by Application (2023-2028)
  • 6.3.3 North America Hepatitis B RNA Detection Technology Market Share by Application (2017-2028)
• 6.4 North America Hepatitis B RNA Detection Technology Market Size by Country
  • 6.4.1 North America Hepatitis B RNA Detection Technology Market Size by Country (2017-2022)
  • 6.4.2 North America Hepatitis B RNA Detection Technology Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Hepatitis B RNA Detection Technology Market Size (2017-2028)
• 7.2 Europe Hepatitis B RNA Detection Technology Market Size by Type
  • 7.2.1 Europe Hepatitis B RNA Detection Technology Market Size by Type (2017-2022)
  • 7.2.2 Europe Hepatitis B RNA Detection Technology Market Size by Type (2023-2028)
  • 7.2.3 Europe Hepatitis B RNA Detection Technology Market Share by Type (2017-2028)
• 7.3 Europe Hepatitis B RNA Detection Technology Market Size by Application
  • 7.3.1 Europe Hepatitis B RNA Detection Technology Market Size by Application (2017-2022)
  • 7.3.2 Europe Hepatitis B RNA Detection Technology Market Size by Application (2023-2028)
  • 7.3.3 Europe Hepatitis B RNA Detection Technology Market Share by Application (2017-2028)
• 7.4 Europe Hepatitis B RNA Detection Technology Market Size by Country
  • 7.4.1 Europe Hepatitis B RNA Detection Technology Market Size by Country (2017-2022)
  • 7.4.2 Europe Hepatitis B RNA Detection Technology Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Hepatitis B RNA Detection Technology Market Size (2017-2028)
• 8.2 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Type
  • 8.2.1 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Hepatitis B RNA Detection Technology Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Application
  • 8.3.1 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Hepatitis B RNA Detection Technology Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Region
  • 8.4.1 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Hepatitis B RNA Detection Technology Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Hepatitis B RNA Detection Technology Market Size (2017-2028)
• 9.2 Latin America Hepatitis B RNA Detection Technology Market Size by Type
  • 9.2.1 Latin America Hepatitis B RNA Detection Technology Market Size by Type (2017-2022)
  • 9.2.2 Latin America Hepatitis B RNA Detection Technology Market Size by Type (2023-2028)
  • 9.2.3 Latin America Hepatitis B RNA Detection Technology Market Share by Type (2017-2028)
• 9.3 Latin America Hepatitis B RNA Detection Technology Market Size by Application
  • 9.3.1 Latin America Hepatitis B RNA Detection Technology Market Size by Application (2017-2022)
  • 9.3.2 Latin America Hepatitis B RNA Detection Technology Market Size by Application (2023-2028)
  • 9.3.3 Latin America Hepatitis B RNA Detection Technology Market Share by Application (2017-2028)
• 9.4 Latin America Hepatitis B RNA Detection Technology Market Size by Country
  • 9.4.1 Latin America Hepatitis B RNA Detection Technology Market Size by Country (2017-2022)
  • 9.4.2 Latin America Hepatitis B RNA Detection Technology Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Hepatitis B RNA Detection Technology Market Size (2017-2028)
• 10.2 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Type
  • 10.2.1 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Hepatitis B RNA Detection Technology Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Application
  • 10.3.1 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Hepatitis B RNA Detection Technology Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Country
  • 10.4.1 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Hepatitis B RNA Detection Technology Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Shanghai Rendu Biotechnology
  • 11.1.1 Shanghai Rendu Biotechnology Company Details
  • 11.1.2 Shanghai Rendu Biotechnology Business Overview
  • 11.1.3 Shanghai Rendu Biotechnology Hepatitis B RNA Detection Technology Introduction
  • 11.1.4 Shanghai Rendu Biotechnology Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.1.5 Shanghai Rendu Biotechnology Recent Developments
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Roche Business Overview
  • 11.2.3 Roche Hepatitis B RNA Detection Technology Introduction
  • 11.2.4 Roche Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.2.5 Roche Recent Developments
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Abbott Business Overview
  • 11.3.3 Abbott Hepatitis B RNA Detection Technology Introduction
  • 11.3.4 Abbott Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.3.5 Abbott Recent Developments
• 11.4 Shengxiang Biotechnology
  • 11.4.1 Shengxiang Biotechnology Company Details
  • 11.4.2 Shengxiang Biotechnology Business Overview
  • 11.4.3 Shengxiang Biotechnology Hepatitis B RNA Detection Technology Introduction
  • 11.4.4 Shengxiang Biotechnology Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.4.5 Shengxiang Biotechnology Recent Developments
• 11.5 Thermo Fisher
  • 11.5.1 Thermo Fisher Company Details
  • 11.5.2 Thermo Fisher Business Overview
  • 11.5.3 Thermo Fisher Hepatitis B RNA Detection Technology Introduction
  • 11.5.4 Thermo Fisher Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.5.5 Thermo Fisher Recent Developments
• 11.6 BGI
  • 11.6.1 BGI Company Details
  • 11.6.2 BGI Business Overview
  • 11.6.3 BGI Hepatitis B RNA Detection Technology Introduction
  • 11.6.4 BGI Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.6.5 BGI Recent Developments
• 11.7 Daan Gene
  • 11.7.1 Daan Gene Company Details
  • 11.7.2 Daan Gene Business Overview
  • 11.7.3 Daan Gene Hepatitis B RNA Detection Technology Introduction
  • 11.7.4 Daan Gene Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.7.5 Daan Gene Recent Developments
• 11.8 Zhijiang Bio
  • 11.8.1 Zhijiang Bio Company Details
  • 11.8.2 Zhijiang Bio Business Overview
  • 11.8.3 Zhijiang Bio Hepatitis B RNA Detection Technology Introduction
  • 11.8.4 Zhijiang Bio Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.8.5 Zhijiang Bio Recent Developments
• 11.9 Soworld Bio
  • 11.9.1 Soworld Bio Company Details
  • 11.9.2 Soworld Bio Business Overview
  • 11.9.3 Soworld Bio Hepatitis B RNA Detection Technology Introduction
  • 11.9.4 Soworld Bio Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.9.5 Soworld Bio Recent Developments
• 11.10 Halotier
  • 11.10.1 Halotier Company Details
  • 11.10.2 Halotier Business Overview
  • 11.10.3 Halotier Hepatitis B RNA Detection Technology Introduction
  • 11.10.4 Halotier Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.10.5 Halotier Recent Developments
• 11.11 Wuhan Zhongqi
  • 11.11.1 Wuhan Zhongqi Company Details
  • 11.11.2 Wuhan Zhongqi Business Overview
  • 11.11.3 Wuhan Zhongqi Hepatitis B RNA Detection Technology Introduction
  • 11.11.4 Wuhan Zhongqi Revenue in Hepatitis B RNA Detection Technology Business (2017-2022)
  • 11.11.5 Wuhan Zhongqi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details

Summary:

Market Analysis and Insights: Global Hepatitis B RNA Detection Technology Market
Serum HBV RNA can better reflect the activity of cccDNA in liver tissue. If the relapse risk of patients is predicted by detecting the level of HBV RNA in serum before drug withdrawal, it will help to identify those who have achieved virological response and are in the "Partially cured" patients who are able to maintain a virological response after drug discontinuation, thereby predicting the risk of virological rebound.
The global Hepatitis B RNA Detection Technology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, RT PCR Technology accounting for % of the Hepatitis B RNA Detection Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Hepatitis B RNA Detection Technology market size is valued at US$ million in 2021, while the North America and Europe Hepatitis B RNA Detection Technology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hepatitis B RNA Detection Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B RNA Detection Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B RNA Detection Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B RNA Detection Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B RNA Detection Technology market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Hepatitis B RNA Detection Technology market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Hepatitis B RNA Detection Technology Breakdown Data by Type
RT PCR Technology
RNA Isothermal Amplification Technology
Hepatitis B RNA Detection Technology Breakdown Data by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Shanghai Rendu Biotechnology
Roche
Abbott
Shengxiang Biotechnology
Thermo Fisher
BGI
Daan Gene
Zhijiang Bio
Soworld Bio
Halotier
Wuhan Zhongqi
Frequently Asked Questions
What factors will challenge the Hepatitis B RNA Detection Technology market growth?
Which end-use segment will expand at the fastest CAGR in the Hepatitis B RNA Detection Technology market?
Which are the emerging players in the Hepatitis B RNA Detection Technology market?
How concentrated is the Hepatitis B RNA Detection Technology market?
Which factors are positively contributing to the Hepatitis B RNA Detection Technology market growth?
Which are the novel product innovations in the Hepatitis B RNA Detection Technology market?
Which product segment will emerge as the most lucrative in the Hepatitis B RNA Detection Technology market?
Which factors are increasing the competition in the Hepatitis B RNA Detection Technology market?
Which are the strategic measures taken by the Hepatitis B RNA Detection Technology industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Hepatitis B RNA Detection Technology market in the coming years?